Irene Marini
Meldola, 47014, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Choline PET/CT in the PSMA Era: Clinical Repositioning, Biological Perspectives, and Emerging Applications.
Journal: Diagnostics (Basel, Switzerland)
Published: June 03, 2026
Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomas.
Journal: Frontiers in medicine
Published: October 20, 2025
Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial.
Journal: Frontiers in oncology
Published: October 08, 2025
PSMA for HCC: a new frontier in precision medicine for liver cancer?
Journal: Cancer treatment and research communications
Published: October 06, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 14, 2025
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 26, 2024
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized Study.
Journal: Neuroendocrinology
Published: June 12, 2024
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 27, 2023
Theragnostic in neuroendocrine tumors.
Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
Published: December 09, 2021
Dynamic 11C-Methionine PET-CT: Prognostic Factors for Disease Progression and Survival in Patients with Suspected Glioma Recurrence.
Journal: Cancers
Published: July 30, 2021
Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 23, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026